PMC:7571312 / 132949-133631 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T52","span":{"begin":348,"end":352},"obj":"Body_part"}],"attributes":[{"id":"A52","pred":"fma_id","subj":"T52","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"The authors would like to thank the Pfizer La Jolla Discovery Technology group who were responsible for all HRMS, preparative HPLC, and SFC separations. Antiviral testing was performed at the Southern Research Institute (Birmingham, AL). The authors wish to thank Dr. Heinz Feldman (NIAID, Hamilton, MT) for the kind gift of the SARS CoV Toronto-2 cell line enabling this testing. The authors wish to thank Cathy Laughlin, Christopher Tseng, and Jack Secrist for their roles in this collaboration. The authors would also like to thank Kevin Freeman-Cook, Charlotte Allerton, and Gina M. Yanochko-Hoffman for critically reading the manuscript and offering valued editing suggestions."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T113","span":{"begin":329,"end":333},"obj":"Disease"}],"attributes":[{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The authors would like to thank the Pfizer La Jolla Discovery Technology group who were responsible for all HRMS, preparative HPLC, and SFC separations. Antiviral testing was performed at the Southern Research Institute (Birmingham, AL). The authors wish to thank Dr. Heinz Feldman (NIAID, Hamilton, MT) for the kind gift of the SARS CoV Toronto-2 cell line enabling this testing. The authors wish to thank Cathy Laughlin, Christopher Tseng, and Jack Secrist for their roles in this collaboration. The authors would also like to thank Kevin Freeman-Cook, Charlotte Allerton, and Gina M. Yanochko-Hoffman for critically reading the manuscript and offering valued editing suggestions."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T224","span":{"begin":163,"end":174},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T225","span":{"begin":250,"end":254},"obj":"http://purl.obolibrary.org/obo/CLO_0009609"},{"id":"T226","span":{"begin":348,"end":357},"obj":"http://purl.obolibrary.org/obo/CLO_0000031"},{"id":"T227","span":{"begin":372,"end":379},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T228","span":{"begin":393,"end":397},"obj":"http://purl.obolibrary.org/obo/CLO_0009609"}],"text":"The authors would like to thank the Pfizer La Jolla Discovery Technology group who were responsible for all HRMS, preparative HPLC, and SFC separations. Antiviral testing was performed at the Southern Research Institute (Birmingham, AL). The authors wish to thank Dr. Heinz Feldman (NIAID, Hamilton, MT) for the kind gift of the SARS CoV Toronto-2 cell line enabling this testing. The authors wish to thank Cathy Laughlin, Christopher Tseng, and Jack Secrist for their roles in this collaboration. The authors would also like to thank Kevin Freeman-Cook, Charlotte Allerton, and Gina M. Yanochko-Hoffman for critically reading the manuscript and offering valued editing suggestions."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T63365","span":{"begin":43,"end":45},"obj":"Chemical"},{"id":"T1072","span":{"begin":73,"end":78},"obj":"Chemical"},{"id":"T8339","span":{"begin":233,"end":235},"obj":"Chemical"},{"id":"T52863","span":{"begin":300,"end":302},"obj":"Chemical"}],"attributes":[{"id":"A65258","pred":"chebi_id","subj":"T63365","obj":"http://purl.obolibrary.org/obo/CHEBI_33336"},{"id":"A82157","pred":"chebi_id","subj":"T1072","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A50542","pred":"chebi_id","subj":"T8339","obj":"http://purl.obolibrary.org/obo/CHEBI_73770"},{"id":"A70879","pred":"chebi_id","subj":"T52863","obj":"http://purl.obolibrary.org/obo/CHEBI_73614"}],"text":"The authors would like to thank the Pfizer La Jolla Discovery Technology group who were responsible for all HRMS, preparative HPLC, and SFC separations. Antiviral testing was performed at the Southern Research Institute (Birmingham, AL). The authors wish to thank Dr. Heinz Feldman (NIAID, Hamilton, MT) for the kind gift of the SARS CoV Toronto-2 cell line enabling this testing. The authors wish to thank Cathy Laughlin, Christopher Tseng, and Jack Secrist for their roles in this collaboration. The authors would also like to thank Kevin Freeman-Cook, Charlotte Allerton, and Gina M. Yanochko-Hoffman for critically reading the manuscript and offering valued editing suggestions."}

{"project":"LitCovid-sentences","denotations":[{"id":"T742","span":{"begin":0,"end":152},"obj":"Sentence"},{"id":"T743","span":{"begin":153,"end":237},"obj":"Sentence"},{"id":"T744","span":{"begin":238,"end":380},"obj":"Sentence"},{"id":"T745","span":{"begin":381,"end":497},"obj":"Sentence"},{"id":"T746","span":{"begin":498,"end":586},"obj":"Sentence"},{"id":"T747","span":{"begin":587,"end":682},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The authors would like to thank the Pfizer La Jolla Discovery Technology group who were responsible for all HRMS, preparative HPLC, and SFC separations. Antiviral testing was performed at the Southern Research Institute (Birmingham, AL). The authors wish to thank Dr. Heinz Feldman (NIAID, Hamilton, MT) for the kind gift of the SARS CoV Toronto-2 cell line enabling this testing. The authors wish to thank Cathy Laughlin, Christopher Tseng, and Jack Secrist for their roles in this collaboration. The authors would also like to thank Kevin Freeman-Cook, Charlotte Allerton, and Gina M. Yanochko-Hoffman for critically reading the manuscript and offering valued editing suggestions."}